Logo image of JUVE.MI

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:JUVE - IT0005572778 - Common Stock

2.456 EUR
-0.03 (-1.05%)
Last: 11/24/2025, 5:29:01 PM
Fundamental Rating

1

Taking everything into account, JUVE scores 1 out of 10 in our fundamental rating. JUVE was compared to 44 industry peers in the Entertainment industry. Both the profitability and financial health of JUVE have multiple concerns. JUVE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JUVE had negative earnings in the past year.
JUVE had a positive operating cash flow in the past year.
JUVE had negative earnings in each of the past 5 years.
In multiple years JUVE reported negative operating cash flow during the last 5 years.
JUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFJUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of JUVE (-7.34%) is worse than 65.91% of its industry peers.
JUVE has a Return On Equity of -439.14%. This is in the lower half of the industry: JUVE underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -7.34%
ROE -439.14%
ROIC N/A
ROA(3y)-17.17%
ROA(5y)-20.44%
ROE(3y)-409.53%
ROE(5y)-798.75%
ROIC(3y)N/A
ROIC(5y)N/A
JUVE.MI Yearly ROA, ROE, ROICJUVE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

JUVE's Gross Margin of 88.51% is fine compared to the rest of the industry. JUVE outperforms 72.73% of its industry peers.
In the last couple of years the Gross Margin of JUVE has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for JUVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y0.02%
JUVE.MI Yearly Profit, Operating, Gross MarginsJUVE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JUVE has about the same amount of shares outstanding.
JUVE has less shares outstanding than it did 5 years ago.
JUVE has a worse debt/assets ratio than last year.
JUVE.MI Yearly Shares OutstandingJUVE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
JUVE.MI Yearly Total Debt VS Total AssetsJUVE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

JUVE has an Altman-Z score of 0.51. This is a bad value and indicates that JUVE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.51, JUVE perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
JUVE has a Debt/Equity ratio of 21.46. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 21.46, JUVE is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 21.46
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC7.22%
JUVE.MI Yearly LT Debt VS Equity VS FCFJUVE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

2.3 Liquidity

JUVE has a Current Ratio of 0.47. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.47, JUVE is not doing good in the industry: 84.09% of the companies in the same industry are doing better.
A Quick Ratio of 0.47 indicates that JUVE may have some problems paying its short term obligations.
JUVE has a worse Quick ratio (0.47) than 84.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
JUVE.MI Yearly Current Assets VS Current LiabilitesJUVE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

JUVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.82%, which is quite impressive.
Looking at the last year, JUVE shows a quite strong growth in Revenue. The Revenue has grown by 18.31% in the last year.
The Revenue has been growing slightly by 1.84% on average over the past years.
EPS 1Y (TTM)70.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.89%
Revenue 1Y (TTM)18.31%
Revenue growth 3Y-0.27%
Revenue growth 5Y1.84%
Sales Q2Q%8.62%

3.2 Future

Based on estimates for the next years, JUVE will show a very negative growth in Earnings Per Share. The EPS will decrease by -17.73% on average per year.
JUVE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.36% yearly.
EPS Next Y-44.39%
EPS Next 2Y17.46%
EPS Next 3Y-17.73%
EPS Next 5YN/A
Revenue Next Year-6.09%
Revenue Next 2Y-2.13%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.36%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JUVE.MI Yearly Revenue VS EstimatesJUVE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
JUVE.MI Yearly EPS VS EstimatesJUVE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUVE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JUVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUVE.MI Price Earnings VS Forward Price EarningsJUVE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JUVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.56
JUVE.MI Per share dataJUVE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as JUVE's earnings are expected to decrease with -17.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.46%
EPS Next 3Y-17.73%

0

5. Dividend

5.1 Amount

No dividends for JUVE!.
Industry RankSector Rank
Dividend Yield N/A

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (11/24/2025, 5:29:01 PM)

2.456

-0.03 (-1.05%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)09-26 2025-09-26/amc
Earnings (Next)02-26 2026-02-26
Inst Owners11.12%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap931.12M
Revenue(TTM)439.76M
Net Income(TTM)-58.15M
Analysts41.82
Price Target2.69 (9.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.71%
PT rev (3m)-11.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-260%
EPS NY rev (3m)-203.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-5.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.12
P/FCF N/A
P/OCF 36.26
P/B 70.32
P/tB N/A
EV/EBITDA 36.56
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)0.07
OCFY2.76%
SpS1.16
BVpS0.03
TBVpS-0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.34%
ROE -439.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.51%
FCFM N/A
ROA(3y)-17.17%
ROA(5y)-20.44%
ROE(3y)-409.53%
ROE(5y)-798.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y0.02%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 21.46
Debt/FCF N/A
Debt/EBITDA 8.67
Cap/Depr 162.73%
Cap/Sales 50.75%
Interest Coverage N/A
Cash Conversion 78.39%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 0.51
F-Score6
WACC7.22%
ROIC/WACCN/A
Cap/Depr(3y)108.07%
Cap/Depr(5y)101.17%
Cap/Sales(3y)37.97%
Cap/Sales(5y)38.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.89%
EPS Next Y-44.39%
EPS Next 2Y17.46%
EPS Next 3Y-17.73%
EPS Next 5YN/A
Revenue 1Y (TTM)18.31%
Revenue growth 3Y-0.27%
Revenue growth 5Y1.84%
Sales Q2Q%8.62%
Revenue Next Year-6.09%
Revenue Next 2Y-2.13%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.36%
EBIT growth 1Y42.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6654%
EBIT Next 3Y290.51%
EBIT Next 5Y135.22%
FCF growth 1Y-31.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.76%
OCF growth 3YN/A
OCF growth 5YN/A

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to JUVE.MI.


Can you provide the valuation status for JUVENTUS FOOTBALL CLUB SPA?

ChartMill assigns a valuation rating of 0 / 10 to JUVENTUS FOOTBALL CLUB SPA (JUVE.MI). This can be considered as Overvalued.


How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) has a profitability rating of 1 / 10.


How financially healthy is JUVENTUS FOOTBALL CLUB SPA?

The financial health rating of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) is 1 / 10.